Dongwei Liu

3.4k citations
151 papers · 2.3k indexed · 1 hit paper · h-index 26
Topics
Chronic Kidney Disease and Diabetes (17 papers)Renal Diseases and Glomerulopathies (15 papers)Cancer-related molecular mechanisms research (13 papers)

In The Last Decade

Dongwei Liu

141 papers receiving 2.3k citations

Hit Papers

Quercetin Ameliorates Diabetic Kidney Injury by Inhibitin...20232026202420252023255075100

Peers

Dongwei Liu
Comparison fields: 5 of 165
  • Molecular Biology 799
  • Nephrology 524
  • Cancer Research 346
  • Pulmonary and Respiratory Medicine 319
  • Epidemiology 193
Replace Zhaohong Chen with:
Zhaohong Chen China
Ping Zhu China
Xuan Wang China
Yanni Wang China
Susumu Shiomi Japan
Fang Liu China
Guochun Chen China
Ke Yang China
Chih‐Hung Chen Taiwan
Xiao Huang China
Dongwei Liu relative to Zhaohong Chen China Zhaohong Chen's profile →
Citations per field
00.5×2.6×
Zhaohong Chen · 1×
Citations per year

Countries citing papers authored by Dongwei Liu

Since Specialization
Citations

This map shows the geographic impact of Dongwei Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongwei Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongwei Liu more than expected).

Fields of papers citing papers by Dongwei Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dongwei Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongwei Liu. The network helps show where Dongwei Liu may publish in the future.

Co-authorship network of co-authors of Dongwei Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Dongwei Liu. A scholar is included among the top collaborators of Dongwei Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dongwei Liu. Dongwei Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 4
3 8
4 28
5 0
6 1
7 1
8 5
9 8
10 6
11 9
12 3
13 3
14 62
15 10
16 15
17 18
18 28
19 1
20
The Stage Feature of Technology Development Level and the New Stage Symbol
1

About Dongwei Liu

Dongwei Liu is a scholar working on Nephrology, Cancer Research and Rehabilitation, having authored 151 papers that have together received 2.3k indexed citations. Recurring topics across this work include Chronic Kidney Disease and Diabetes (17 papers), Renal Diseases and Glomerulopathies (15 papers) and Cancer-related molecular mechanisms research (13 papers). The work is most often cited by research in Nephrology (524 citations), Cancer Research (346 citations) and Neurology (105 citations). Dongwei Liu has collaborated with scholars based in China, United States and New Zealand. Frequent co-authors include Zhangsuo Liu, Shaokang Pan, Qi Feng, Zhangsuo Liu, Fengxun Liu, Yanfang Lu, Yingjin Qiao, Ye Ma, Jiayu Duan and Yingjin Qiao. Their work appears in journals such as PLoS ONE, Scientific Reports and Brain Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026